Anistreplase

From WikiMD.org
Jump to navigation Jump to search

Anistreplase

Anistreplase (pronounced: an-is-trep-lase) is a thrombolytic agent used in the treatment of acute myocardial infarction (heart attack) and other conditions related to blood clotting.

Etymology

The term 'Anistreplase' is derived from the words 'anisoylated' and 'streptokinase'. 'Anisoylated' refers to the process of attaching an anisoyl group to another molecule, in this case, streptokinase. 'Streptokinase' is an enzyme produced by certain strains of streptococci bacteria, which has the ability to dissolve blood clots.

Usage

Anistreplase is used as a thrombolytic agent, which means it helps to dissolve blood clots. It is often used in the treatment of acute myocardial infarction, also known as a heart attack. It works by activating the plasminogen in the body, which then breaks down the fibrin in blood clots.

Related Terms

  • Thrombolytic: A type of drug that dissolves blood clots.
  • Acute myocardial infarction: A medical term for a heart attack.
  • Streptococci: A type of bacteria that can cause a variety of infections.
  • Plasminogen: A protein in the blood that is converted into plasmin, an enzyme that dissolves blood clots.
  • Fibrin: A protein involved in the clotting of blood.

See Also

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski